Recruiting

A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis (ADhere-J)

J2T-JE-KGAL - ClinicalTrials.gov - NCT04760314

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in combination with a topical corticosteroids in Japanese participants with atopic dermatitis.
How long will I be in the trial?
Your participation could last about 78 weeks and may include up to 25 visits to the study center.
Email
Recruiting

A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis (ADhere-J)

J2T-JE-KGAL - ClinicalTrials.gov - NCT04760314

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in combination with a topical corticosteroids in Japanese participants with atopic dermatitis.
How long will I be in the trial?
Your participation could last about 78 weeks and may include up to 25 visits to the study center.
Email

Key Requirements

Age :

12+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

12+

Sex

All

Participants must

Participant must be an adult or adolescent (12 to <18years) and weighing ≥40 kilogram (kg)

Participants must have atopic dermatitis that has been present for at least one year

Participants must have ≥10% body surface area (BSA) of atopic dermatitis involvement

Participants must have had an inadequate response to topical medications (medications applied to the skin)

Participants must NOT

Participants must not have received a vaccine within 12 weeks of starting the study

Participants must not have hepatitis

Participants must not have a history of HIV

Participants must not have a history of cancer within 5 years

Female participants must not be pregnant, breastfeeding or plan to become pregnant during the study

Trial Summary

Conditions the trial is for

Atopic Dermatitis (Eczema), Pediatric Atopic Dermatitis (Eczema)

What the trial is testing?

Lebrikizumab, Topical Corticosteroid

Could I receive a Placebo?

yes

Enrollment Goal

280

Trial Dates

March 2021 - May 2023

Trial Phase

3

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

12+

Sex

All

Participants must

Participant must be an adult or adolescent (12 to <18years) and weighing ≥40 kilogram (kg)

Participants must have atopic dermatitis that has been present for at least one year

Participants must have ≥10% body surface area (BSA) of atopic dermatitis involvement

Participants must have had an inadequate response to topical medications (medications applied to the skin)

Participants must NOT

Participants must not have received a vaccine within 12 weeks of starting the study

Participants must not have hepatitis

Participants must not have a history of HIV

Participants must not have a history of cancer within 5 years

Female participants must not be pregnant, breastfeeding or plan to become pregnant during the study

Trial Summary

Conditions the trial is for

Atopic Dermatitis (Eczema), Pediatric Atopic Dermatitis (Eczema)

What the trial is testing?

Lebrikizumab, Topical Corticosteroid

Could I receive a Placebo?

yes

Enrollment Goal

280

Trial Dates

March 2021 - May 2023

Trial Phase

3

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?